P J Houghton Selected Research

P J Houghton Research Topics

Disease

21	Neoplasms (Cancer) 11/2016 - 01/2000
5	Neuroblastoma 01/2008 - 01/2000
4	Rhabdomyosarcoma 05/2015 - 01/2000
2	Infections 01/2006 - 04/2001
2	Wounds and Injuries (Trauma) 01/2006 - 10/2001
2	Alzheimer Disease (Alzheimer's Disease) 11/2002 - 10/2001
2	Glioblastoma (Glioblastoma Multiforme) 11/2001 - 10/2000
2	Glioma (Gliomas) 10/2000 - 01/2000
2	Central Nervous System Neoplasms 10/2000 - 01/2000
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2016
1	Ewing Sarcoma (Sarcoma, Ewing) 05/2015
1	Parasitemia 03/2009
1	Malaria 03/2009
1	AIDS-Related Complex (ARC) 01/2008
1	Large Cell Carcinoma 07/2005
1	Parkinson Disease (Parkinson's Disease) 06/2003
1	Hypertrophy 11/2002
1	Medulloblastoma 09/2001
1	Neoplasm Metastasis (Metastasis) 09/2001
1	Residual Neoplasm 09/2001
1	Colonic Neoplasms (Colon Cancer) 06/2001
1	Melanoma (Melanoma, Malignant) 12/2000
1	Dementia (Dementias) 07/2000

Drug/Important Bio-Agent (IBA)

6	Irinotecan (Camptosar)FDA LinkGeneric 03/2008 - 01/2000
4	Proteins (Proteins, Gene)FDA Link 05/2015 - 03/2000
3	Methylene Chloride (Dichloromethane)IBA 03/2010 - 12/2000
3	TOR Serine-Threonine KinasesIBA 10/2006 - 12/2001
3	Sirolimus (Rapamycin)FDA Link 10/2006 - 04/2001
3	Topotecan (Hycamtin)FDA LinkGeneric 09/2001 - 01/2000
3	Temozolomide (Temodar)FDA LinkGeneric 10/2000 - 03/2000
2	Oncogene Proteins (Oncogene Protein)IBA 05/2015 - 01/2000
2	Estrogens (Estrogen)FDA Link 11/2002 - 10/2001
2	AntioxidantsIBA 10/2001 - 10/2001
2	Insulin-Like Growth Factor I (IGF-1)IBA 01/2000 - 01/2000
1	N- propyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (PPTP)IBA 11/2016
1	EWS-FLI fusion proteinIBA 05/2015
1	pinostrobinIBA 03/2010
1	Plant Preparations (Preparation, Plant)IBA 03/2010
1	StilbenesIBA 03/2010
1	Plant ExtractsIBA 03/2009
1	Ethanol (Ethyl Alcohol)IBA 03/2009
1	EnzymesIBA 03/2008
1	SurvivinIBA 01/2008
1	pyrimidineIBA 01/2008
1	Caspase 3 (Caspase-3)IBA 01/2008
1	Dichlororibofuranosylbenzimidazole (DRB)IBA 01/2008
1	NucleosidesIBA 01/2008
1	AlkaloidsIBA 01/2007
1	acridoneIBA 01/2007
1	benzamideIBA 01/2007
1	MTOR InhibitorsIBA 10/2006
1	Phosphotransferases (Kinase)IBA 10/2006
1	Somatomedin Receptors (Somatomedin Receptor)IBA 01/2004
1	Dihydroxyphenylalanine (Dopa)IBA 06/2003
1	Oxidoreductases (Dehydrogenase)IBA 06/2003
1	Levodopa (L Dopa)FDA LinkGeneric 06/2003
1	Dopamine (Intropin)FDA LinkGeneric 06/2003
1	citral (neral)IBA 11/2002
1	geraniol (nerol)IBA 11/2002
1	antineoplaston A10 (A 10)IBA 11/2001
1	irofulvenIBA 11/2001
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 10/2001
1	Volatile Oils (Essential Oils)IBA 10/2001
1	caffeic acidIBA 10/2001
1	FlavonoidsIBA 10/2001
1	Filgrastim (Neupogen)FDA Link 09/2001
1	temsirolimus FDA Link 06/2001
1	Eukaryotic Initiation Factor-4EIBA 06/2001
1	EstersIBA 06/2001
1	Cyclin AIBA 04/2001
1	9-aminocamptothecin lactoneIBA 02/2001
1	9-aminocamptothecinIBA 02/2001
1	Topoisomerase I InhibitorsIBA 02/2001
1	isopinnatalIBA 12/2000
1	lissamine rhodamine B (sulforhodamine B)IBA 12/2000
1	norviburtinalIBA 12/2000
1	CamptothecinIBA 10/2000
1	Antineoplastic Agents (Antineoplastics)IBA 10/2000
1	imidazoleIBA 10/2000
1	Cholinesterases (Cholinesterase)IBA 07/2000
1	Cholinergic Agents (Cholinergics)IBA 07/2000
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 03/2000
1	MethyltransferasesIBA 03/2000
1	RNA (Ribonucleic Acid)IBA 01/2000
1	Mitogen-Activated Protein KinasesIBA 01/2000
1	Etoposide (VP 16)FDA LinkGeneric 01/2000
1	Cisplatin (Platino)FDA LinkGeneric 01/2000
1	Carmustine (FIVB)FDA Link 01/2000
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 01/2000
1	Vincristine (Oncovin)FDA LinkGeneric 01/2000
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2000

Therapy/Procedure

7	Therapeutics 11/2016 - 01/2000
2	Drug Therapy (Chemotherapy) 11/2016 - 08/2000
1	Traditional Medicine (Folk Remedies) 01/2006
1	Estrogen Replacement Therapy 11/2002